PATIENT INCLUSIVITY - Inclusivity, collaboration and targeted care
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
Thought Leadership, 20 February 2025Achieving inclusivity for minorities in clinical trials; Why local knowledge is key for pharmacovigilance; EU vs US trends in clinical trials
Avalere Health’s Amar Urhekar on his career path; Insights from ASH 2024; The science behind gene-silencing technology
Sanofi’s John Forni on the escalating challenges of treating COPD; The need for a human touch in an AI world; PMGroup celebrates the 24th PMEAs!
The explosive growth of Gen AI; Liberating patient pathways; Closing health equity gaps
Boehringer Ingelheim’s Ulrike Graefe-Mody on her career path; Driving launch excellence; Top trends coming out of ESMO 2024
The challenges of environmental sustainability; ‘Causes That Count, Health’ report; Rethinking neurodegeneration
Merck’s Doina Ionescu on her professional journey; Full coverage of Communiqué 2024; Omnichannel opportunities
GSK’s Jack Harris on innovation in oncology; Harnessing creativity in a digital age; Sustainability in pharma
Interview with Ipsen’s Ioana Parsons on her new role; Celebrating comms excellence; Getting trial diversity right
Astellas' Marci English on managing the menopause; Clinigen’s Lorna Pender on treating rare diseases; the science behind behaviour change
Interview with Sanofi’s Rippon Ubhi on her new role; Optimising MS care and patient outcomes; Overcoming pharma web strategy challenges
Diversity, equity and inclusion in medical research; Marking International Day of Women and Girls in Science; Incentivising innovation in antibiotics
Interview with AstraZeneca’s Ed Piper on patient outcomes; Pharma trends and predictions for 2024; Precision medicine in chronic diseases
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
Thought Leadership, 20 February 2025What value does your strategic planning add?
Thought Leadership, 20 February 2025CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
Thought Leadership, 22 January 2025What value does your strategic planning add?
Thought Leadership, 22 January 2025Roche and Ascidian agree to $1.8bn neurological disease partnership
Researchers identify new major cause of inflammatory bowel disease
UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa
The evolutionary lessons for Bayer’s management restructure
Collecting the right data in the right way for the right reasons
How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?
Roche and Ascidian agree to $1.8bn neurological disease partnership
Researchers identify new major cause of inflammatory bowel disease
UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa
The evolutionary lessons for Bayer’s management restructure
Collecting the right data in the right way for the right reasons
How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?
Roche and Ascidian agree to $1.8bn neurological disease partnership
Researchers identify new major cause of inflammatory bowel disease
Across almost every sector, brands are multiplying their investment in creativity
Features, 20 February 2025Picking your omnichannel direction requires a disciplined, scientific approach
Features, 20 February 2025Ethical content sharing and the benefits of the CLA Pharmaceutical Licence
Features, 20 February 2025Across almost every sector, brands are multiplying their investment in creativity
Features, 22 January 2025Picking your omnichannel direction requires a disciplined, scientific approach
Features, 22 January 2025Ethical content sharing and the benefits of the CLA Pharmaceutical Licence
Features, 22 January 2025‘Patient engagement is both a process and a behaviour throughout the drug life cycle’
Communique - Marketing & Comms, 20 February 2025‘Patient engagement is both a process and a behaviour throughout the drug life cycle’
Communique - Marketing & Comms, 22 January 2025